Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net income	$ 985,000	$ 1,653,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	1,156,000	863,000
Amortization of intangible assets	815,000	638,000
Non-cash lease adjustment	46,000	(2,000)
Stock compensation expense	319,000	413,000
Provision for credit losses	30,000	8,000
Provision for excess and obsolete inventory		140,000
Amortization of deferred financing costs	30,000	10,000
Changes in operating assets and liabilities:
Accounts receivable	(4,166,000)	(2,468,000)
Inventories	(1,068,000)	(941,000)
Prepaid expenses and other assets	(638,000)	(725,000)
Accounts payable	(794,000)	(1,798,000)
Other accrued liabilities	1,052,000	(1,128,000)
Total adjustments	(3,218,000)	(4,990,000)
Net cash used in operating activities	(2,233,000)	(3,337,000)
Cash flows from investing activities:
Purchase of property, plant and equipment	(1,889,000)	(1,353,000)
Acquisition of My Medic	(14,412,000)
Net cash used in investing activities	(16,301,000)	(1,353,000)
Cash flows from financing activities:
Net borrowings of long-term debt	21,159,000	2,816,000
Cash settlement of stock options	(1,462,000)	(463,000)
Repayments on mortgage	(77,000)	(99,000)
Proceeds from issuance of common stock	97,000
Distributions to shareholders	(610,000)	(563,000)
Net cash provided by financing activities	19,107,000	1,691,000
Effect of exchange rate changes on cash and cash equivalents	27,000	46,000
Net change in cash and cash equivalents	600,000	(2,953,000)
Cash and cash equivalents at beginning of period	3,596,000	6,399,000
Cash and cash equivalents at end of period	4,196,000	3,446,000
Supplemental cash flow information:
Cash paid for income taxes	80,000	85,000
Cash paid for interest	$ 380,000	$ 368,000